HY-3000

N/A

Report date: 2026/04/09 15:16:00
NME

Base Information

Drug NameHY-3000
Drug Alias NameHY3000鼻喷雾剂HY-3000
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHybio Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHybio Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A